改进肺炎抗生素选择的抗菌药物管理提示:INSPIRE随机临床试验
INSPIRE是一项在59家美国社区医院进行的整群随机试验,比较CPOE抗菌药物管理组合(教育、反馈和基于MDRO风险的实时CPOE提示)与常规抗菌药物管理对非重症肺炎住院成人经验性抗生素选择的影响。干预组对MDRO肺炎估计绝对风险<10%但被开具广谱抗生素的患者,提示推荐标准谱抗生素。结果显示干预组经验性广谱抗生素治疗天数较常规组减少28.4%(率比0.72,95%CI 0.66-0.78,P<.001)。安全结局方面,ICU转入平均天数(6.5 vs 7.1天)和住院时长(6.8 vs 7.1天)两组无显著差异。
要点
- 在59家美国社区医院非重症肺炎住院成人中,CPOE提示组经验性广谱抗生素治疗天数较常规管理组减少28.4%(率比0.72,95%CI 0.66-0.78,P<.001)。
- CPOE提示适用于经验性治疗期被开具广谱抗生素、且MDRO肺炎估计绝对风险<10%的非重症(非ICU)住院成人肺炎患者。
- 干预措施为CPOE提示推荐标准谱抗生素,并联合反馈与教育。
- 安全结局:ICU转入平均天数常规组6.5天 vs CPOE干预组7.1天,住院时长常规组6.8天 vs CPOE干预组7.1天,均无显著差异。
- 研究纳入96 451例成人肺炎住院患者(基线期51 671例,干预期44 780例),平均(SD)年龄68.1(17.0)岁,48.1%为男性,Elixhauser合并症计数中位数(IQR)为4(2-6)。
适用人群与场景
- 非重症(非ICU)成人(≥18岁)肺炎住院患者。
- 研究场景为59家美国社区医院。
- 基线期2017年4月1日至2018年9月30日(18个月),干预期2019年4月1日至2020年6月30日(15个月)。
诊断标准与关键阈值
- CPOE提示触发条件:经验性治疗期(住院前3天)被开具广谱抗生素,且MDRO肺炎估计绝对风险<10%。
处置流程与药物剂量
- CPOE提示推荐对MDRO肺炎估计绝对风险<10%但被开具广谱抗生素的非重症肺炎住院成人使用标准谱抗生素。
- 干预组合包括教育、反馈和基于MDRO风险的实时CPOE提示。
研究设计与关键结果
- 研究类型:整群随机临床试验,59家美国社区医院(CPOE管理组合组29家,常规管理组30家),纳入96 451例成人肺炎住院患者(基线期51 671例,干预期44 780例)。
- 人群特征:平均(SD)年龄68.1(17.0)岁,48.1%为男性,Elixhauser合并症计数中位数(IQR)为4(2-6)。
- 主要终点:与常规管理相比,CPOE提示组经验性广谱抗生素治疗天数减少28.4%(率比0.72,95%CI 0.66-0.78,P<.001)。
- 安全结局:ICU转入平均天数常规组6.5天 vs CPOE干预组7.1天,住院时长常规组6.8天 vs CPOE干预组7.1天,均无显著差异。
- 次要终点:经验性万古霉素和抗假单胞菌治疗天数。
证据类型、等级与局限
- 证据类型:整群随机临床试验。
- 试验注册号:ClinicalTrials.gov NCT03697070。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对非重症肺炎住院成人,在经验性治疗期被开具广谱抗生素且MDRO肺炎估计绝对风险<10%时,CPOE提示推荐标准谱抗生素可减少经验性广谱抗生素治疗天数。
- 该干预未改变ICU转入时间和住院时长。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Pneumonia is the most common infection requiring hospitalization and is a major reason for overuse of extended-spectrum antibiotics. Despite low risk of multidrug-resistant organism (MDRO) infection, clinical uncertainty often drives initial antibiotic selection. Strategies to limit empiric antibiotic overuse for patients with pneumonia are needed.
OBJECTIVE: To evaluate whether computerized provider order entry (CPOE) prompts providing patient- and pathogen-specific MDRO infection risk estimates could reduce empiric extended-spectrum antibiotics for non-critically ill patients admitted with pneumonia.
DESIGN, SETTING, AND PARTICIPANTS: Cluster-randomized trial in 59 US community hospitals comparing the effect of a CPOE stewardship bundle (education, feedback, and real-time MDRO risk-based CPOE prompts; n = 29 hospitals) vs routine stewardship (n = 30 hospitals) on antibiotic selection during the first 3 hospital days (empiric period) in non-critically ill adults (≥18 years) hospitalized with pneumonia. There was an 18-month baseline period from April 1, 2017, to September 30, 2018, and a 15-month intervention period from April 1, 2019, to June 30, 2020.
INTERVENTION: CPOE prompts recommending standard-spectrum antibiotics in patients ordered to receive extended-spectrum antibiotics during the empiric period who have low estimated absolute risk (<10%) of MDRO pneumonia, coupled with feedback and education.
MAIN OUTCOMES AND MEASURES: The primary outcome was empiric (first 3 days of hospitalization) extended-spectrum antibiotic days of therapy. Secondary outcomes included empiric vancomycin and antipseudomonal days of therapy and safety outcomes included days to intensive care unit (ICU) transfer and hospital length of stay. Outcomes compared differences between baseline and intervention periods across strategies.
RESULTS: Among 59 hospitals with 96 451 (51 671 in the baseline period and 44 780 in the intervention period) adult patients admitted with pneumonia, the mean (SD) age of patients was 68.1 (17.0) years, 48.1% were men, and the median (IQR) Elixhauser comorbidity count was 4 (2-6). Compared with routine stewardship, the group using CPOE prompts had a 28.4% reduction in empiric extended-spectrum days of therapy (rate ratio, 0.72 [95% CI, 0.66-0.78]; P < .001). Safety outcomes of mean days to ICU transfer (6.5 vs 7.1 days) and hospital length of stay (6.8 vs 7.1 days) did not differ significantly between the routine and CPOE intervention groups.
CONCLUSIONS AND RELEVANCE: Empiric extended-spectrum antibiotic use was significantly lower among adults admitted with pneumonia to non-ICU settings in hospitals using education, feedback, and CPOE prompts recommending standard-spectrum antibiotics for patients at low risk of MDRO infection, compared with routine stewardship practices. Hospital length of stay and days to ICU transfer were unchanged.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03697070.
参考来源
- Gohil SK, Septimus E, Kleinman K, et al. Stewardship Prompts to Improve Antibiotic Selection for Pneumonia: The INSPIRE Randomized Clinical Trial. JAMA. 2024. PMID: 38639729. doi:10.1001/jama.2024.6248
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。